crossnma: An R package to synthesize cross-design evidence and cross-format data using network meta-analysis and network meta-regression

Tasnim Hamza,Guido Schwarzer,Georgia Salanti
DOI: https://doi.org/10.1186/s12874-023-02130-0
2024-08-06
BMC Medical Research Methodology
Abstract:Although aggregate data (AD) from randomised clinical trials (RCTs) are used in the majority of network meta-analyses (NMAs), other study designs (e.g., cohort studies and other non-randomised studies, NRS) can be informative about relative treatment effects. The individual participant data (IPD) of the study, when available, are preferred to AD for adjusting for important participant characteristics and to better handle heterogeneity and inconsistency in the network.
health care sciences & services
What problem does this paper attempt to address?